Development of Long-Acting GLP-1 Receptor Antagonist for the Treatment of Congenital Hyperinsulinism

被引：0
|
作者：
Yuan, Yue
Jiang, Haowen
Meng, Shi
Han, Dongna
Zhu, Qiusha
Wang, Manchen
Li, Hushan
Li, Jia
Li, Changhong
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-842-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
842-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The Clinical Impact of GLP-1 Receptor Agonists in Type 2 Diabetes: Focus on the Long-Acting Analogs
    Rodbard, Helena W.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : 33 - 41
  • [22] Clinically significant emesis in a patient taking a long-acting GLP-1 receptor agonist for weight loss
    Weber, Marissa
    Siddarthan, Ingharan
    Fogarty, Patricia
    BRITISH JOURNAL OF ANAESTHESIA, 2023, 131 (02) : e37 - e39
  • [23] Long-Acting Injectable GLP-1 Receptor Agonists for the Treatment of Adults with Type 2 Diabetes: Perspectives from Clinical Practice
    Morieri, Mario Luca
    Avogaro, Angelo
    Fadini, Gian Paolo
    DIABETES METABOLIC SYNDROME AND OBESITY, 2020, 13 : 4221 - 4234
  • [24] Long acting GLP-1 for the treatment of type 2 diabetes
    Reichstetter, Sandra
    Castillo, Gerardo
    Perfetti, Riccardo
    Leahy, Mark
    Bolotin, Elijah
    DIABETES, 2007, 56 : A144 - A144
  • [25] Long Acting GLP-1 Analog Treatment in Islet Transplantation
    Peixoto, E. M. L.
    Mireles-Zavala, L. G.
    Bozkurt, N. C.
    Delmonte, V.
    Corrales, A.
    Ricordi, C.
    Alejandro, R.
    TRANSPLANTATION, 2012, 94 (10) : 706 - 706
  • [26] Long acting GLP-1 for the treatment of type I diabetes
    Reichstetter, Sandra
    Castillo, Gerardo
    Medarova, Zdravka
    Moore, Anna
    Perfetti, Riccardo
    Leahy, Mark
    Bolotin, Elijah
    DIABETES, 2007, 56 : A73 - A73
  • [27] Assessing the Effect of a Long-Acting GLP-1 Agonist on Onset of Puberty in Rats
    Thompson, K. E.
    Buss, N.
    Stewart, J.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2015, 103 (05) : 373 - 373
  • [28] Glycemic and Metabolic Effects of Long-Acting GLP-1 in T1D
    Mohandas, Deene
    Gao, Catherine
    Calma, Jamie
    Basina, Marina
    DIABETES, 2022, 71
  • [29] Identification and utility exploration of a highly potent and long-acting bullfrog GLP-1 analogue in GLP-1 and amylin combination therapy
    Sun, Xiao
    Yang, Dawei
    Li, Yan
    Shi, Jingjing
    Zhang, Xiaolong
    Yi, Tingzhuang
    PEPTIDES, 2024, 177
  • [30] Peptide complex containing GLP-1 exhibited long-acting properties in the treatment of type 2 diabetes
    Zheng, Xuemin
    Li, Ying
    Li, Xin
    Tang, Lida
    Xu, Weiren
    Gong, Min
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 (03) : 410 - 420
12345